 Nikoloz Shkriabai
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 12 | 2025 | 908 | 0.980 |
Why?
| | HIV Integrase | 9 | 2017 | 74 | 0.980 |
Why?
| | HIV Integrase Inhibitors | 5 | 2016 | 79 | 0.680 |
Why?
| | Human T-lymphotropic virus 1 | 5 | 2023 | 32 | 0.650 |
Why?
| | Acetates | 2 | 2014 | 78 | 0.520 |
Why?
| | Virus Integration | 9 | 2022 | 69 | 0.510 |
Why?
| | Anti-HIV Agents | 4 | 2025 | 912 | 0.380 |
Why?
| | Protein Binding | 17 | 2021 | 2238 | 0.330 |
Why?
| | Indoles | 1 | 2014 | 507 | 0.320 |
Why?
| | DNA, Viral | 5 | 2017 | 356 | 0.300 |
Why?
| | Drug Resistance, Viral | 3 | 2014 | 126 | 0.290 |
Why?
| | Virus Replication | 4 | 2025 | 521 | 0.270 |
Why?
| | Mutation, Missense | 3 | 2014 | 335 | 0.270 |
Why?
| | Gene Products, tax | 2 | 2019 | 15 | 0.260 |
Why?
| | HEK293 Cells | 11 | 2020 | 741 | 0.260 |
Why?
| | Cell Cycle Proteins | 5 | 2017 | 630 | 0.250 |
Why?
| | Intercellular Signaling Peptides and Proteins | 4 | 2013 | 376 | 0.240 |
Why?
| | Viral Nonstructural Proteins | 2 | 2016 | 63 | 0.240 |
Why?
| | RNA, Viral | 4 | 2017 | 692 | 0.220 |
Why?
| | Integrases | 3 | 2017 | 122 | 0.220 |
Why?
| | Hepacivirus | 2 | 2016 | 242 | 0.220 |
Why?
| | Acetamides | 1 | 2025 | 41 | 0.210 |
Why?
| | DNA Damage | 3 | 2021 | 437 | 0.210 |
Why?
| | Indazoles | 1 | 2025 | 85 | 0.210 |
Why?
| | Virus Assembly | 1 | 2025 | 82 | 0.210 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 3 | 2021 | 69 | 0.210 |
Why?
| | Leukemia Virus, Murine | 2 | 2014 | 17 | 0.200 |
Why?
| | Y-Box-Binding Protein 1 | 1 | 2023 | 5 | 0.200 |
Why?
| | Capsid | 2 | 2021 | 94 | 0.200 |
Why?
| | Protein Multimerization | 2 | 2014 | 204 | 0.180 |
Why?
| | Transcription Factors | 3 | 2017 | 1734 | 0.180 |
Why?
| | Prions | 1 | 2022 | 56 | 0.180 |
Why?
| | Nucleosomes | 2 | 2014 | 163 | 0.170 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 53 | 0.160 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 85 | 0.160 |
Why?
| | Necrosis | 1 | 2021 | 244 | 0.160 |
Why?
| | Protein Interaction Domains and Motifs | 4 | 2019 | 145 | 0.160 |
Why?
| | Neuroblastoma | 1 | 2021 | 174 | 0.150 |
Why?
| | HTLV-I Infections | 3 | 2019 | 29 | 0.150 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 48 | 0.140 |
Why?
| | Host-Pathogen Interactions | 4 | 2021 | 361 | 0.140 |
Why?
| | Receptors, Virus | 1 | 2019 | 95 | 0.140 |
Why?
| | Nuclear Proteins | 2 | 2014 | 740 | 0.140 |
Why?
| | Avian Leukosis Virus | 1 | 2017 | 6 | 0.130 |
Why?
| | Allosteric Regulation | 2 | 2014 | 99 | 0.130 |
Why?
| | High Mobility Group Proteins | 1 | 2017 | 45 | 0.130 |
Why?
| | Transcriptional Elongation Factors | 1 | 2017 | 39 | 0.120 |
Why?
| | DNA-Binding Proteins | 2 | 2017 | 1480 | 0.120 |
Why?
| | Cyclophilin A | 1 | 2016 | 27 | 0.120 |
Why?
| | Mass Spectrometry | 7 | 2016 | 730 | 0.120 |
Why?
| | Ribonuclease P | 1 | 2016 | 22 | 0.120 |
Why?
| | Nucleic Acids | 1 | 2016 | 70 | 0.120 |
Why?
| | Virion | 1 | 2016 | 108 | 0.120 |
Why?
| | Catalytic Domain | 1 | 2016 | 234 | 0.110 |
Why?
| | Models, Molecular | 7 | 2017 | 1598 | 0.110 |
Why?
| | RNA, Transfer | 1 | 2016 | 143 | 0.110 |
Why?
| | Calcium | 1 | 2021 | 1190 | 0.110 |
Why?
| | DEAD-box RNA Helicases | 2 | 2016 | 83 | 0.110 |
Why?
| | Genome, Viral | 1 | 2016 | 214 | 0.110 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 43 | 0.110 |
Why?
| | Hepatitis C | 1 | 2016 | 256 | 0.100 |
Why?
| | Quinolines | 1 | 2014 | 190 | 0.100 |
Why?
| | Transcription Initiation Site | 1 | 2013 | 43 | 0.100 |
Why?
| | Capsid Proteins | 2 | 2025 | 94 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 440 | 0.100 |
Why?
| | beta Karyopherins | 1 | 2012 | 9 | 0.090 |
Why?
| | Cell Nucleus | 2 | 2021 | 588 | 0.090 |
Why?
| | Protein Domains | 3 | 2020 | 311 | 0.090 |
Why?
| | Viral Proteins | 1 | 2014 | 350 | 0.090 |
Why?
| | Crystallography, X-Ray | 3 | 2020 | 486 | 0.090 |
Why?
| | Amino Acid Motifs | 3 | 2021 | 219 | 0.090 |
Why?
| | Protein Processing, Post-Translational | 1 | 2014 | 471 | 0.090 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2009 | 143 | 0.090 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2022 | 28 | 0.090 |
Why?
| | Amino Acid Sequence | 4 | 2019 | 2129 | 0.090 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2022 | 40 | 0.090 |
Why?
| | HIV Reverse Transcriptase | 1 | 2011 | 31 | 0.090 |
Why?
| | Leukemia-Lymphoma, Adult T-Cell | 1 | 2011 | 17 | 0.080 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2011 | 87 | 0.080 |
Why?
| | Viral Core Proteins | 1 | 2011 | 21 | 0.080 |
Why?
| | Humans | 24 | 2025 | 145474 | 0.080 |
Why?
| | 5' Untranslated Regions | 1 | 2010 | 59 | 0.080 |
Why?
| | HIV Infections | 2 | 2025 | 3193 | 0.080 |
Why?
| | Aptamers, Nucleotide | 1 | 2011 | 87 | 0.080 |
Why?
| | Virology | 1 | 2010 | 36 | 0.080 |
Why?
| | Protein Interaction Mapping | 1 | 2010 | 105 | 0.080 |
Why?
| | Recombinant Proteins | 1 | 2013 | 1368 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 155 | 0.080 |
Why?
| | Xeroderma Pigmentosum Group A Protein | 1 | 2009 | 4 | 0.080 |
Why?
| | Protein Structure, Tertiary | 4 | 2013 | 855 | 0.070 |
Why?
| | Binding Sites | 3 | 2021 | 1310 | 0.070 |
Why?
| | DNA Footprinting | 1 | 2008 | 33 | 0.070 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 321 | 0.070 |
Why?
| | Autoantigens | 1 | 2011 | 427 | 0.070 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 452 | 0.070 |
Why?
| | Cryoelectron Microscopy | 2 | 2020 | 221 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 441 | 0.070 |
Why?
| | DNA Repair | 1 | 2009 | 254 | 0.060 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 384 | 0.060 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2021 | 117 | 0.060 |
Why?
| | HeLa Cells | 2 | 2020 | 632 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 1140 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 17 | 0.050 |
Why?
| | Genes, Viral | 1 | 2023 | 88 | 0.050 |
Why?
| | Cell Line | 3 | 2014 | 2823 | 0.050 |
Why?
| | Drugs, Investigational | 1 | 2022 | 31 | 0.050 |
Why?
| | Phenylalanine | 1 | 2022 | 69 | 0.050 |
Why?
| | Phosphorylation | 2 | 2021 | 1707 | 0.040 |
Why?
| | Glycine | 1 | 2022 | 186 | 0.040 |
Why?
| | Nuclear Pore | 1 | 2021 | 19 | 0.040 |
Why?
| | Reverse Transcription | 1 | 2021 | 20 | 0.040 |
Why?
| | Lentiviruses, Primate | 1 | 2021 | 12 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2023 | 637 | 0.040 |
Why?
| | Deuterium Exchange Measurement | 1 | 2020 | 26 | 0.040 |
Why?
| | Cytoplasm | 1 | 2021 | 254 | 0.040 |
Why?
| | Protein Conformation | 2 | 2014 | 938 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2021 | 563 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 886 | 0.040 |
Why?
| | PDZ Domains | 1 | 2019 | 11 | 0.040 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 10 | 0.040 |
Why?
| | Sorting Nexins | 1 | 2019 | 12 | 0.040 |
Why?
| | Chromatography, Gel | 2 | 2009 | 130 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2023 | 1246 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2015 | 2883 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 611 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 333 | 0.030 |
Why?
| | Virulence | 1 | 2019 | 278 | 0.030 |
Why?
| | Histones | 2 | 2014 | 666 | 0.030 |
Why?
| | Chick Embryo | 1 | 2017 | 132 | 0.030 |
Why?
| | Nucleoside-Triphosphatase | 1 | 2016 | 13 | 0.030 |
Why?
| | Nucleoproteins | 1 | 2017 | 38 | 0.030 |
Why?
| | Cell Survival | 2 | 2011 | 1100 | 0.030 |
Why?
| | DNA | 2 | 2014 | 1435 | 0.030 |
Why?
| | Nucleocapsid | 1 | 2016 | 19 | 0.030 |
Why?
| | Conserved Sequence | 1 | 2017 | 244 | 0.030 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2016 | 93 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 2016 | 128 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2016 | 141 | 0.030 |
Why?
| | Morphogenesis | 1 | 2016 | 172 | 0.030 |
Why?
| | DNA Helicases | 1 | 2016 | 136 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2016 | 387 | 0.030 |
Why?
| | Retroviridae Proteins | 1 | 2014 | 10 | 0.030 |
Why?
| | Histidine | 1 | 2014 | 66 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 5216 | 0.030 |
Why?
| | Mutant Proteins | 1 | 2014 | 105 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1356 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 762 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 146 | 0.020 |
Why?
| | Base Sequence | 1 | 2016 | 2170 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 139 | 0.020 |
Why?
| | Azepines | 1 | 2013 | 105 | 0.020 |
Why?
| | Scattering, Small Angle | 1 | 2012 | 22 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2440 | 0.020 |
Why?
| | X-Ray Diffraction | 1 | 2012 | 83 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 192 | 0.020 |
Why?
| | Circular Dichroism | 1 | 2012 | 151 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 302 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2015 | 572 | 0.020 |
Why?
| | Triazoles | 1 | 2013 | 187 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 666 | 0.020 |
Why?
| | Protein Footprinting | 1 | 2011 | 11 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1852 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1764 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 475 | 0.020 |
Why?
| | G2 Phase | 1 | 2011 | 39 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2011 | 115 | 0.020 |
Why?
| | Hydroxyl Radical | 1 | 2011 | 86 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2010 | 54 | 0.020 |
Why?
| | Retroviridae | 1 | 2010 | 100 | 0.020 |
Why?
| | Protein Subunits | 1 | 2011 | 229 | 0.020 |
Why?
| | Animals | 4 | 2017 | 38030 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2010 | 216 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 179 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2013 | 530 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2011 | 172 | 0.020 |
Why?
| | Cell Division | 1 | 2011 | 756 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 116 | 0.020 |
Why?
| | Point Mutation | 1 | 2009 | 240 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2008 | 371 | 0.020 |
Why?
| | Proteomics | 1 | 2013 | 1188 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3542 | 0.010 |
Why?
| | Proteins | 1 | 2010 | 1023 | 0.010 |
Why?
| | Peptides | 1 | 2009 | 998 | 0.010 |
Why?
| | Mutation | 1 | 2008 | 4075 | 0.010 |
Why?
| | Mice | 1 | 2013 | 18329 | 0.010 |
Why?
|
|
Shkriabai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|